Biomimetic cell-derived nanocarriers for modulating immune responses

Area of Science:

• Biomedical Engineering
• Immunology
• Nanotechnology

Background:

• Immunotherapy is a rapidly growing medical field.
• Synthetic carriers face regulatory challenges for clinical use.
• Bionic cell-derived carriers present a promising alternative due to superior biocompatibility and reduced toxicity.

Purpose of the Study:

• To review advanced technologies for bionic cell-derived carriers.
• To summarize applications of these carriers in modulating immune responses.
• To discuss future clinical translation prospects.

Main Methods:

• Extracellular vesicle-based formulation technology.
• Cell membrane coating technology.
• Review of current research and applications.

Main Results:

• Biomimetic nanocarriers can elicit specific biological effects based on host cell properties.
• These technologies enable diverse applications for immune response modulation.
• Significant progress has been made in developing these advanced carriers.

Conclusions:

• Bionic cell-derived carriers, utilizing advanced biomimetic technologies, show great potential for clinical applications in immunotherapy.
• Further development is expected to overcome current limitations and promote wider adoption.
• Understanding these technologies is key to advancing their therapeutic use.